Nonproliferative Breast Changes Fibrocystic Changes

Slide 1 · Nonproliferative Breast Changes

(Fibrocystic Changes)

Morphology • mechanisms • clinical correlation

Dr Abu Suraih Sakhri

MBBS, MD (Pathology)

www.abusuraihsakhri.com

Slide 2 · Learning objectives

Classify nonproliferative changes within benign epithelial lesions.

Explain cyst formation, apocrine metaplasia, stromal fibrosis, and adenosis.

Relate microscopic changes to palpable masses, nodularity, and calcifications.

Differentiate these changes from proliferative lesions and interpret cancer-risk grouping.

Slide 3 · The benign epithelial lesion spectrum

Nonproliferative changes

Cysts, apocrine change, fibrosis, and adenosis.

Proliferative without atypia

Epithelial hyperplasia or sclerosing proliferations without atypia.

Proliferative with atypia

Atypical clonal epithelial proliferations.

Slide 4 · The terminal duct lobular unit is the key context

Most benign epithelial lesions arise in the terminal duct lobular unit.

Its acinar–ductal architecture provides the framework for cystic dilation and adenosis.

Abnormalities can alter epithelial lining, acinar number, and supporting stroma.

Schematic

Slide 5 · “Fibrocystic change” is a morphologic umbrella

A group of common breast changes rather than one discrete neoplasm.

Three major components: Cystic change, fibrosis, and adenosis.

Apocrine metaplasia commonly accompanies cyst formation.

Different components can coexist within a breast.

Slide 6 · Typical age distribution: 30–50 years

These changes are especially common between ages 30 and 50.

Menstrual hormonal fluctuations as a possible contributing influence.

Hormonal association is presented as a possibility, not a proven single cause.

Schematic

Slide 7 · Why “nonproliferative” is imperfect

Historical label

Biologic nuance

No associated increase in breast cancer risk defines the historical category.

The category is primarily clinicopathologic and risk-based.

Some constituent changes include increased epithelial proliferation.

Some may show clonal genetic aberrations.

Slide 8 · The three core tissue responses

Cystic dilation

Expansion of acinar/lobular spaces; Often apocrine-lined.

Stromal fibrosis

Response to cyst rupture with inflammation and collagenous repair.

Adenosis

Increase in acini within an individual lobule.

Slide 9 · Why the same process looks different clinically

Microscopic alterations

Possible presentation

Altered acinar lumen size

Epithelial metaplasia

Local secretions or calcifications

Diffuse or focal nodularity

Palpable solitary cyst

Mammographic calcifications

Slide 10 · Detection is often incidental

Benign epithelial changes are commonly found at mammography or incidentally in surgical material.

Diffuse nodularity may reflect normal glandular tissue or fibrocystic change.

A discrete palpable lesion requires clinical evaluation rather than diagnosis by label alone.

Slide 11 · Read each lesion along three axes

What changed?

Space, epithelial phenotype, acinar number, or stromal repair.

What is its substrate?

Lobule, cyst wall, or interstitial stroma.

Why is it noticed?

Palpable mass, nodularity, calcification, or incidentally.

Slide 12 · Cysts begin with lobular dilation

Small cysts arise through dilation of lobular structures.

Enlarging spaces may coalesce into larger cysts.

The architecture is one of luminal expansion, not necessarily a new solid tumor.

Schematic

Slide 13 · Small cysts can merge into larger spaces

Lobular dilatation

Initially small cysts

Coalescence

Neighboring cystic spaces enlarge

Macroscopic cyst

May present as a palpable mass

Cyst size helps explain why some are incidental and others are clinically apparent.

Slide 14 · A typical unopened cyst contains turbid fluid

Contents may be semitranslucent, brown, or blue tinged.

The gross appearance underlies the term “blue-dome cyst.”

This description concerns typical cyst fluid, not a universal appearance.

Schematic

Slide 15 · The cyst lining may become flattened

One lining pattern is flattened, atrophic epithelium.

Expansion can coexist with epithelial attenuation.

A thin lining does not exclude a prominent gross cyst.

Schematic

Slide 16 · A second lining pattern is apocrine metaplasia

The cyst lining can instead comprise metaplastic apocrine cells.

Apocrine epithelium resembles that of normal sweat glands.

This cell change is part of the nonproliferative lesion spectrum.

Schematic

Slide 17 · Two epithelial appearances in a cyst wall

Flattened / atrophic

Apocrine metaplasia

Low-profile cells

Thin-appearing lining

Seen in cystically expanded lobules

Plump epithelial cells

Abundant eosinophilic cytoplasm

Granular cytoplasmic texture

Slide 18 · Apocrine cells have granular eosinophilic cytoplasm

Abundant cytoplasm is a defining microscopic clue.

Granularity and pink staining help recognize the cell phenotype on H&E.

The appearance resembles sweat-gland apocrine epithelium.

Schematic

Slide 19 · A cyst wall may contain different epithelial patterns

Cystic morphology refers to luminal enlargement.

Epithelial lining phenotype is a separate microscopic observation.

Therefore, “cyst” and “apocrine metaplasia” are compatible, not competing diagnoses.

Schematic

Slide 20 · Calcifications frequently accompany cystic change

Calcification is a common finding in fibrocystic cysts.

The textbook figure describes deposits on secretory debris within cyst lumens.

Calcifications may bring a benign lesion to radiologic attention.

Schematic

Slide 21 · Calcification: Tissue observation versus imaging clue

Histologic location

Clinical detection

Intraluminal deposits

Association with secretory material

Can accompany apocrine-lined cysts

Visible as mammographic calcifications

Can prompt sampling or correlation

Not a diagnosis of malignancy by itself

Slide 22 · A single firm cyst can simulate a mass

Many cysts cause no concern; Solitary firm cysts may be palpable.

The physical presentation can lead to concern for an underlying tumor.

The diagnostic question is whether the finding is a simple cyst or a persistent solid lesion.

Schematic

Slide 23 · Aspiration can demonstrate a fluid-filled cyst

Palpable cystic mass

Clinical examination identifies concern

Fine-needle aspiration

Fluid is removed from lesion

Disappearance of mass

Textbook confirmation for the cyst

Disappearance of the mass after aspiration as confirmation.

Slide 24 · Aspiration provides a structure–symptom correlation

Before aspiration: A cavity filled with fluid can be felt as a mass.

After fluid removal: The cavity collapses and the palpable mass resolves.

The change in physical finding supports the cystic basis of the mass.

Slide 25 · Three distinct observations about a breast cyst

Gross

Turbid brown/blue fluid in an expanded cavity.

Microscopic

Flat atrophic or apocrine epithelial lining; Calcification may be seen.

Clinical

May be found as a solitary palpable mass; Aspiration can resolve it.

Slide 26 · Application: The solitary “blue-dome” lesion

CLINICAL / MORPHOLOGIC STEM

A 39-year-old patient has a discrete breast lump. At examination a cystic lesion is suspected; Aspiration evacuates brown-tinged fluid and the mass disappears.

INTERPRETATION

Lobular dilation produces the fluid-filled cavity.

Cyst fluid may be brown or blue tinged.

Disappearance after aspiration supports a cyst.

Most consistent process: Nonproliferative cystic change.

Slide 27 · Fibrosis commonly follows rupture of a cyst

Cysts may rupture and release secretory material into the stroma.

Material outside the epithelial-lined space induces a tissue response.

Fibrosis is therefore linked to prior cystic injury in this context.

Schematic

Slide 28 · Rupture connects cystic change to stromal scarring

Cyst rupture

Secretory material escapes

Chronic inflammation

Adjacent stroma reacts

Fibrosis

Repair creates collagenous nodularity

This is the source-defined mechanism for many palpable fibrocystic nodules.

Slide 29 · Extravasated secretions drive inflammation

Secretory material is normally contained within a lined lumen.

Rupture relocates it into adjacent interstitium.

The tissue develops a chronic inflammatory reaction around released material.

Schematic

Slide 30 · Stromal repair produces collagenous nodularity

Fibrosis follows chronic inflammation after cyst rupture.

Firmness or nodularity can arise from the stromal component.

The palpable abnormality need not be produced by a solid epithelial proliferation.

Schematic

Slide 31 · Fluid and fibrous tissue produce different findings

Fluid-filled cyst

Fibrotic nodularity

An epithelial-lined, expanded lumen

Luminal liquid contributes to volume

Mass may resolve on aspiration

Stromal scarring follows chronic inflammation

Collagen-rich tissue produces firmness

Not simply a cavity of aspiratable fluid

Slide 32 · The stroma is an active participant

Fibrocystic change is not solely an epithelial abnormality.

Ruptured cysts affect supporting interstitial tissue.

Reactive fibrosis helps determine what is palpable.

Schematic

Slide 33 · Application: Diffuse palpable nodularity

CLINICAL / MORPHOLOGIC STEM

A 44-year-old patient reports diffusely nodular breast tissue. Histology reveals prior cystic spaces with adjacent stromal fibrosis.

INTERPRETATION

Cyst rupture may release material into stroma.

Inflammation and scarring follow.

Fibrosis explains the palpable nodularity.

Mechanistic link: Cyst rupture → stromal fibrosis.

Slide 34 · Distinguish three components of a fibrocystic nodule

Epithelial space

Cystic dilation, sometimes apocrine-lined.

Inflammatory response

Reaction to secretory material when cysts rupture.

Stromal outcome

Collagenous fibrosis creating palpable irregularity.

Slide 35 · Adenosis means more acini per lobule

The defining feature is an increase in acinar number.

The unit of comparison is an individual lobule.

Adenosis describes glandular abundance rather than an enlarged cyst lumen.

Schematic

Slide 36 · Normal lobule versus adenosis

Reference architecture

Adenosis

Smaller number of acini in the lobule

Individual acinar lumens are identifiable

Increased number of acini per lobule

Preserved glandular/acinar profile

May include intraluminal calcifications

Slide 37 · Acini in adenosis may have columnar epithelium

Columnar cells lining the increased acini.

The diagnostic feature combines epithelial lining with the count of acini.

Increased acinar number is distinct from cyst expansion.

Schematic

Slide 38 · Adenosis may show luminal calcification

Calcifications occasionally occur within acinar lumina.

Intraluminal mineralization is compatible with a benign acinar process.

Microscopic location helps relate the finding to mammographic detection.

Schematic

Slide 39 · Simple adenosis versus sclerosing adenosis

Adenosis in this topic

Sclerosing adenosis: Adjacent topic

More acini in a lobule

Acini may be columnar-lined

No defining compression by dense fibrosis

Increased acini plus stromal fibrosis

Distortion and compression of glandular profiles

Belongs to proliferative disease without atypia

Slide 40 · Application: Increased acini without marked sclerosis

CLINICAL / MORPHOLOGIC STEM

A tissue sample shows a lobule containing more acini than expected. These acini have columnar epithelium; Occasional calcification is present.

INTERPRETATION

The defining change is acinar number.

Columnar lining accords with simple adenosis.

Calcification can occur in lumens.

Best term: Adenosis within nonproliferative change.

Slide 41 · What to count, inspect, and localize in adenosis

Count

Acini per lobule.

Inspect

Epithelial lining character.

Localize

Any calcifications inside lumina.

Slide 42 · Cysts and adenosis modify different dimensions

Cysts: Increased luminal size as lobular spaces dilate.

Adenosis: Increased acinar number within a lobule.

Fibrosis: Increased stromal collagen following injury/inflammation.

These dimensions can coexist but should be reported separately.

Slide 43 · Lactational adenoma is a special associated alteration

Lactational adenoma among other “nonproliferative” morphologic changes.

It presents as a mass during pregnancy or lactation.

Its hormonal setting differentiates it from the typical nonlactational changes.

Schematic

Slide 44 · Histology resembles breast tissue in lactation

The mass contains normal-appearing tissue with lactational changes.

The lesion may represent an exaggerated localized response to gestational hormones.

Robbins cautions that it may not be a true neoplasm.

Schematic

Slide 45 · Lactational adenoma follows a characteristic setting

Pregnancy or lactation

Gestational endocrine stimulus

Palpable breast mass

Localized lactational tissue

After breastfeeding

Regression can occur

Natural regression supports the proposed hormone-responsive biology.

Slide 46 · Regression after breastfeeding is a diagnostic clue

Lactational adenomas may regress following cessation of breastfeeding.

Natural-history observation is part of their clinicopathologic identity.

Regression is consistent with an exaggerated gestational response.

Schematic

Slide 47 · Lactational adenoma versus fibrocystic cyst

Lactational adenoma

Fibrocystic cyst

Pregnant or breastfeeding setting

Lactational-appearing breast tissue

Tends to regress after lactation

Lobular dilation with cyst cavity

Flat or apocrine lining

May produce a mass resolving on aspiration

Slide 48 · Application: A mass during lactation

CLINICAL / MORPHOLOGIC STEM

A lactating patient has a well-defined breast mass. Sampled tissue shows normal-appearing breast epithelium with lactational changes, rather than cystic dilation.

INTERPRETATION

Clinical setting is pregnancy/breastfeeding.

Morphology shows a local lactational response.

The lesion may regress after breastfeeding ends.

Most consistent lesion: Lactational adenoma.

Slide 49 · Breast lesion groups are defined by risk

Category

Representative changes

Relative risk

Nonproliferative

Cysts, apocrine change, adenosis

1.0

Proliferative / no atypia

Sclerosing adenosis, florid UDH

1.5–2

With atypia

Atypical ductal/lobular hyperplasia

4–5

Carcinoma in situ

DCIS or LCIS

8–10

Slide 50 · Relative risk is not histologic intensity

Pathologic appearance

Clinical risk category

Benign changes may have prominent cysts, apocrine epithelium, or nodularity.

Some show proliferation despite the group name.

Nonproliferative group: Relative risk 1.0.

Atypia elevates risk category independent of mere palpability.

Slide 51 · Atypia is a crucial boundary between groups

Nonproliferative changes are grouped as lacking an elevated subsequent carcinoma risk.

Proliferative disease without atypia has a small increase in subsequent risk.

Proliferative disease with atypia carries a larger increase in risk.

These are classifications of subsequent risk, not synonymous with invasive cancer.

Slide 52 · Simple adenosis and sclerosing adenosis are not interchangeable

Simple adenosis

Sclerosing adenosis

More acini per lobule

Belongs to nonproliferative changes

Relative-risk category 1.0

Fibrous distortion and compression of acini

Proliferative disease without atypia

Higher category relative risk 1.5–2

Slide 53 · Calcifications must be interpreted in context

Cystic change and adenosis can contain calcifications.

Mammography may detect them even if a lesion is not palpable.

Calcification alone does not determine the lesion’s biologic risk category.

Schematic

Slide 54 · The lesion is approached at three scales

Patient

Palpable mass, diffuse nodularity, or incidental detection.

Image

A mass/density or calcifications may prompt assessment.

Tissue

Cyst lining, acinar number, and fibrosis establish the pattern.

Slide 55 · The “nonproliferative” label does not mean no genetic change

Some morphologic changes include epithelial proliferation.

Clonal genetic aberrations may occur in some of them.

Risk categorization remains clinically distinct from any one molecular observation.

Slide 56 · Interpreting a benign breast finding

Presentation

Palpable, imaging, or incidental

Morphologic feature

Cyst / apocrine change / fibrosis / adenosis

Risk group

Nonproliferative versus proliferative / atypical

A diagnosis should describe the pattern before applying its risk category.

Slide 57 · Integrative case: Calcified apocrine-lined cyst

CLINICAL / MORPHOLOGIC STEM

A mammographically detected lesion has a dilated cystic lumen, luminal mineralization and epithelial cells with abundant granular eosinophilic cytoplasm.

INTERPRETATION

Luminal dilation identifies a cyst.

Granular eosinophilic cells identify apocrine metaplasia.

Calcifications can accompany this benign pattern.

Classification: Fibrocystic change; Cyst with apocrine metaplasia.

Slide 58 · Integrative case: Cyst plus stromal scarring

CLINICAL / MORPHOLOGIC STEM

Microscopy shows an expanded lobular space, disruption of the lining and adjacent dense collagenous tissue. The breast feels nodular.

INTERPRETATION

A prior cyst can rupture.

Released secretion induces chronic inflammation.

Fibrotic repair explains the clinically firm area.

Mechanism: Rupture-associated stromal fibrosis.

Slide 59 · Integrative case: The misleading category name

CLINICAL / MORPHOLOGIC STEM

A biopsy is labeled nonproliferative fibrocystic change. A trainee argues that absolutely no epithelial proliferation can be present.

INTERPRETATION

The term is historical and risk-based.

Some included alterations increase epithelial proliferation.

The label does not exclude possible clonal aberrations.

Correction: “nonproliferative” is not biologically literal.

Slide 60 · Integrative case: Two lesions called adenosis

CLINICAL / MORPHOLOGIC STEM

Specimen A has many columnar-lined acini in a lobule. Specimen B has glandular multiplication with prominent distortion and compression by fibrosis.

INTERPRETATION

A fits simple adenosis.

B fits sclerosing adenosis.

The lesions occupy different Robbins risk groups.

Specify the pattern; The word “adenosis” alone is insufficient.

Slide 61 · Morphologic recognition checklist

Component

Defining observation

Clinical correlate

Cyst

Dilated lobular lumen; variable epithelial lining

Solitary mass; may collapse on aspiration

Apocrine change

Granular eosinophilic epithelial cytoplasm

Often lines cysts

Fibrosis

Stromal scarring after cyst rupture

Palpable nodularity

Adenosis

More acini per lobule

Occasional luminal calcifications

Lactational adenoma

Lactational-appearing tissue

Pregnancy/lactation-associated mass

Slide 62 · Core concepts to retain

Fibrocystic change combines cysts, apocrine metaplasia, fibrosis, and adenosis.

Cyst rupture can cause chronic inflammation and stromal scarring.

Simple adenosis increases acinar number; Sclerosing adenosis is a separate proliferative pattern.

The nonproliferative category is defined by a relative-risk grouping, not a literal absence of cell proliferation.

Slide 63 · Reference and image-use note

Primary source

Robbins, Cotran & Kumar: Pathologic Basis of Disease. 11th ed. (2026). Chapter 23: The Breast, pp. 945–952; especially pp. 947–948 and Table 23.1.

All tissue drawings are original, editable schematics, not histology images. No textbook figures have been reproduced.